Page last updated: 2024-12-06

bw 12c79

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-(2-formyl-3-hydroxyphenoxy)pentanoic acid: aromatic aldehyde; aldehyde group interacts with N-terminal amino group of both alpha-globin chains [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72162
CHEMBL ID2107643
SCHEMBL ID61907
MeSH IDM0118500

Synonyms (31)

Synonym
12c79
bw-12c
velaresol
12C ,
bw12c79
pentanoic acid, 5-(2-formyl-3-hydroxyphenoxy)-
bw 12c79
einecs 278-778-8
5-(2-formyl-3-hydroxyphenoxy)valeric acid
5-(2-formyl-3-hydroxyphenoxy)pentanoic acid
bw 12c
bw12c
77858-21-0
CHEMBL2107643
unii-9eqv0xq79b
9eqv0xq79b ,
velaresol [inn:ban]
SCHEMBL61907
velaresol [mart.]
velaresol [inn]
DTXSID30228472
NSUDGNLOXMLAEB-UHFFFAOYSA-N
AKOS032960434
5-(2-formyl-3-hydroxy-phenoxy)pentanoic acid
BCP20750
12c79; bw 12c; bw 12c79
N16837
Q27272458
bw-12c79
HY-106509
CS-0025953

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" However, BW12C in combination with MMC for 5-FU-resistant colorectal cancer is not an effective regimen."( Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
Braybrooke, JP; Dixon, RM; Ganesan, TS; Harris, AL; Levitt, NC; Littlewood, TJ; O'Byrne, K; Propper, DJ; Rajagopalan, B; Talbot, DC; Thompson, CH, 2000
)
0.31

Dosage Studied

ExcerptRelevanceReference
" The effects were analyzed using quantal dose-response data and comparisons were made using ED50 values for moist desquamation."( Modification of the radiation response of pig skin by manipulation of tissue oxygen tension using anesthetics and administration of BW12C.
Barnes, DW; Hopewell, JW; Nethersell, AB; Sansom, JM; van den Aardweg, GJ, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1755537Volume of distribution in human at 20 mg/kg, iv measured over 1 hr2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.
AID1755535AUC (0 to 24 hrs) in human at 20 mg/kg, iv measured over 1 hr2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.
AID1755538Elimination half life in human at 20 mg/kg, iv measured over 1 hr2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.
AID1755539Ratio of drug level in human erythrocytes to plasma at 20 mg/kg, iv measured over 1 hr2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.
AID1755536Clearance in human at 20 mg/kg, iv measured over 1 hr2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (38.71)18.7374
1990's15 (48.39)18.2507
2000's3 (9.68)29.6817
2010's0 (0.00)24.3611
2020's1 (3.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.75 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index4.41 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (18.75%)5.53%
Reviews1 (3.13%)6.00%
Case Studies1 (3.13%)4.05%
Observational0 (0.00%)0.25%
Other24 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]